F

FutureChem Co Ltd
KOSDAQ:220100

Watchlist Manager
FutureChem Co Ltd
KOSDAQ:220100
Watchlist
Price: 15 780 KRW 2.67%
Market Cap: 348.7B KRW
Have any thoughts about
FutureChem Co Ltd?
Write Note

Net Margin
FutureChem Co Ltd

-67.2%
Current
-77%
Average
0.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-67.2%
=
Net Income
-10.6B
/
Revenue
15.7B

Net Margin Across Competitors

Country KR
Market Cap 348.7B KRW
Net Margin
-67%
Country US
Market Cap 1.2T USD
Net Margin
9%
Country US
Market Cap 202.3B USD
Net Margin
14%
Country US
Market Cap 166.6B USD
Net Margin
18%
Country KR
Market Cap 66.8T KRW
Net Margin
24%
Country CH
Market Cap 38.4B CHF
Net Margin
9%
Country US
Market Cap 38.8B USD
Net Margin
20%
Country US
Market Cap 36.3B USD
Net Margin
9%
Country US
Market Cap 27B USD
Net Margin
21%
Country US
Market Cap 24.1B USD
Net Margin
17%
Country CN
Market Cap 162B CNY
Net Margin
21%
No Stocks Found

FutureChem Co Ltd
Glance View

Market Cap
348.7B KRW
Industry
Life Sciences Tools & Services

FutureChem Co., Ltd. engages in the manufacture of medical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2015-08-13. Co.,Ltd is a Korea-based company principally engaged in the manufacture and distribution of radiopharmaceuticals. The firm manufactures radiopharmaceuticals including radiopharmaceuticals for diagnosis of various cancers such as lung cancer and for the early diagnosis of Parkinson's disease and Alzheimer's disease. The firm also produces medical automation modules such as cubes and disposable goods including disposable cassettes, reagent kits, radio-caps and kryptofix kits; productions of photon emission tomography (PET) and single photon emission computed tomography (SPECT) precursors for radiopharmaceuticals and other chemicals such as metal chelating agents, fluorescence probes, peptides.

Intrinsic Value
1 218.19 KRW
Overvaluation 92%
Intrinsic Value
Price
F

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-67.2%
=
Net Income
-10.6B
/
Revenue
15.7B
What is the Net Margin of FutureChem Co Ltd?

Based on FutureChem Co Ltd's most recent financial statements, the company has Net Margin of -67.2%.